These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

578 related items for PubMed ID: 8272088

  • 21. [Therapy of systemic mycoses in neutropenic patients using itraconazole. A comparative, randomized study with amphotericin B].
    van't Wout JW, Novakova I, Verhagen CA, Fibbe WE, de Pauw BE, van der Meer JW.
    Med Klin (Munich); 1991 Dec; 86 Suppl 1():11-3. PubMed ID: 1663200
    [Abstract] [Full Text] [Related]

  • 22. [Therapy of systemic mycoses in immunodeficiency].
    Just-Nübling G, Stille W.
    Immun Infekt; 1991 Aug; 19(4):116-20. PubMed ID: 1937558
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Azole drug resistance in yeasts.
    Johnson EM, Warnock DW.
    J Antimicrob Chemother; 1995 Nov; 36(5):751-5. PubMed ID: 8626255
    [No Abstract] [Full Text] [Related]

  • 30. Emerging disease issues and fungal pathogens associated with HIV infection.
    Ampel NM.
    Emerg Infect Dis; 1996 Nov; 2(2):109-16. PubMed ID: 8903210
    [Abstract] [Full Text] [Related]

  • 31. Itraconazole: a new triazole antifungal agent.
    Zuckerman JM, Tunkel AR.
    Infect Control Hosp Epidemiol; 1994 Jun; 15(6):397-410. PubMed ID: 8083506
    [Abstract] [Full Text] [Related]

  • 32. Azole antifungal agents: emphasis on new triazoles.
    Saag MS, Dismukes WE.
    Antimicrob Agents Chemother; 1988 Jan; 32(1):1-8. PubMed ID: 2831809
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Pharmacokinetic optimisation of oral antifungal therapy.
    Schäfer-Korting M.
    Clin Pharmacokinet; 1993 Oct; 25(4):329-41. PubMed ID: 8261715
    [Abstract] [Full Text] [Related]

  • 37. Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
    Polak A.
    Chemotherapy; 1987 Oct; 33(5):381-95. PubMed ID: 2822362
    [Abstract] [Full Text] [Related]

  • 38. Combination therapy for systemic mycosis.
    Polak A.
    Infection; 1989 Oct; 17(4):203-9. PubMed ID: 2548963
    [No Abstract] [Full Text] [Related]

  • 39. Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses.
    Grant SM, Clissold SP.
    Drugs; 1989 Mar; 37(3):310-44. PubMed ID: 2540949
    [Abstract] [Full Text] [Related]

  • 40. Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations.
    Tucker RM, Denning DW, Hanson LH, Rinaldi MG, Graybill JR, Sharkey PK, Pappagianis D, Stevens DA.
    Clin Infect Dis; 1992 Jan; 14(1):165-74. PubMed ID: 1315160
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.